N
NovoCure Limited
NVCR
21.410
USD
-1.37
(-6.01%)
مغلق
حجم التداول
21,926
الربح لكل سهم
0
العائد الربحي
0
P/E
-10
حجم السوق
1,746,630,289
العنوان: NovoCure Limited
القطاع: Healthcare
الصناعة: Medical Devices
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatmentof solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derivesmajority of its revenue from the United States and rest from Germany, Japan and other markets.